Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
PRNewsWire
·
2026-05-15
·
via The Tech Buzz - Press Releases
TORONTO, May 14, 2026 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), the largest Canadian‑based glob…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。